• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

NeoGenomics Inc

+ Add to Watchlist


3.1500 USD 0.0400 1.29%

As of 20:10:00 ET on 04/17/2014.

Snapshot for NeoGenomics Inc (NEO)

Open: 3.0900 Day's Range: 3.0300 - 3.2100 Volume: 82,895
Previous Close: 3.1100 52wk Range: 2.0500 - 4.6900 1-Yr Rtn: -19.75%

Stock Chart for NEO

No chart data available.
  • NEO:US 3.1500
  • 1D
  • 1M
  • 1Y
Interactive NEO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NEO

Current P/E Ratio (ttm) 63.0000
Estimated P/E(12/2014) 175.0000
Relative P/E vs. SPX 3.6634
Earnings Per Share (USD) (ttm) 0.0500
Est. EPS (USD) (12/2014) 0.0180
Est. PEG Ratio 7.7778
Market Cap (M USD) 154.73
Shares Outstanding (M) 49.12
30 Day Average Volume 179,213
Price/Book (mrq) 7.1265
Price/Sale (ttm) 2.2919
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NEO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NEO

NeoGenomics, Inc. operates a network of clinical laboratories that specialize in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Douglas M VanoortChairman/CEOGeorge A CardozaChief Financial Officer
Steven A RossChief Information OfficerMaher AlbitarChief Medical Officer
More Company Profile & Key Executives for NEO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil